Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 99

1.

Anti-Chikungunya viral activities of aplysiatoxin-related compounds from the marine cyanobacterium Trichodesmium erythraeum.

Gupta DK, Kaur P, Leong ST, Tan LT, Prinsep MR, Chu JJ.

Mar Drugs. 2014 Jan 3;12(1):115-27. doi: 10.3390/md12010115.

2.

Lagunamide C, a cytotoxic cyclodepsipeptide from the marine cyanobacterium Lyngbya majuscula.

Tripathi A, Puddick J, Prinsep MR, Rottmann M, Chan KP, Chen DY, Tan LT.

Phytochemistry. 2011 Dec;72(18):2369-75. doi: 10.1016/j.phytochem.2011.08.019. Epub 2011 Sep 6.

PMID:
21903231
3.

Activity of andrographolide against chikungunya virus infection.

Wintachai P, Kaur P, Lee RC, Ramphan S, Kuadkitkan A, Wikan N, Ubol S, Roytrakul S, Chu JJ, Smith DR.

Sci Rep. 2015 Sep 18;5:14179. doi: 10.1038/srep14179.

4.

2,3-seco-2,3-dioxo-lyngbyatoxin A from a Red Sea strain of the marine cyanobacterium Moorea producens.

Youssef DT, Shaala LA, Mohamed GA, Ibrahim SR, Banjar ZM, Badr JM, McPhail KL, Risinger AL, Mooberry SL.

Nat Prod Res. 2015;29(8):703-9. doi: 10.1080/14786419.2014.982647. Epub 2014 Nov 25.

PMID:
25421266
5.

Natural products chemistry and taxonomy of the marine cyanobacterium Blennothrix cantharidosmum.

Clark BR, Engene N, Teasdale ME, Rowley DC, Matainaho T, Valeriote FA, Gerwick WH.

J Nat Prod. 2008 Sep;71(9):1530-7. doi: 10.1021/np800088a. Epub 2008 Aug 13.

6.

Nhatrangins A and B, aplysiatoxin-related metabolites from the marine cyanobacterium Lyngbya majuscula from Vietnam.

Chlipala GE, Pham HT, Nguyen VH, Krunic A, Shim SH, Soejarto DD, Orjala J.

J Nat Prod. 2010 Apr 23;73(4):784-7. doi: 10.1021/np100002q.

7.

Inhibitors of alphavirus entry and replication identified with a stable Chikungunya replicon cell line and virus-based assays.

Pohjala L, Utt A, Varjak M, Lulla A, Merits A, Ahola T, Tammela P.

PLoS One. 2011;6(12):e28923. doi: 10.1371/journal.pone.0028923. Epub 2011 Dec 19.

8.

Bisebromoamide, a potent cytotoxic peptide from the marine cyanobacterium Lyngbya sp.: isolation, stereostructure, and biological activity.

Teruya T, Sasaki H, Fukazawa H, Suenaga K.

Org Lett. 2009 Nov 5;11(21):5062-5. doi: 10.1021/ol9020546.

PMID:
19803465
9.

Antillatoxin B, a neurotoxic lipopeptide from the marine cyanobacterium Lyngbya majuscula.

Nogle LM, Okino T, Gerwick WH.

J Nat Prod. 2001 Jul;64(7):983-5.

PMID:
11473443
10.
11.

Malyngolide dimer, a bioactive symmetric cyclodepside from the panamanian marine cyanobacterium Lyngbya majuscula.

GutiƩrrez M, Tidgewell K, Capson TL, Engene N, Almanza A, Schemies J, Jung M, Gerwick WH.

J Nat Prod. 2010 Apr 23;73(4):709-11. doi: 10.1021/np9005184.

12.

Apratoxin D, a potent cytotoxic cyclodepsipeptide from papua new guinea collections of the marine cyanobacteria Lyngbya majuscula and Lyngbya sordida.

GutiƩrrez M, Suyama TL, Engene N, Wingerd JS, Matainaho T, Gerwick WH.

J Nat Prod. 2008 Jun;71(6):1099-103. doi: 10.1021/np800121a. Epub 2008 Apr 30.

PMID:
18444683
13.

Lyngbyaloside B, a new glycoside macrolide from a Palauan marine cyanobacterium, Lyngbya sp.

Luesch H, Yoshida WY, Harrigan GG, Doom JP, Moore RE, Paul VJ.

J Nat Prod. 2002 Dec;65(12):1945-8.

PMID:
12502348
14.

Biochemical studies of the lagunamides, potent cytotoxic cyclic depsipeptides from the marine cyanobacterium Lyngbya majuscula.

Tripathi A, Fang W, Leong DT, Tan LT.

Mar Drugs. 2012 May;10(5):1126-37. doi: 10.3390/md10051126. Epub 2012 May 23.

15.

Apratoxin E, a cytotoxic peptolide from a guamanian collection of the marine cyanobacterium Lyngbya bouillonii.

Matthew S, Schupp PJ, Luesch H.

J Nat Prod. 2008 Jun;71(6):1113-6. doi: 10.1021/np700717s. Epub 2008 May 8.

PMID:
18461997
16.

Antiherpetic efficacy of aqueous extracts of the cyanobacterium Arthrospira fusiformis from Chad.

Sharaf M, Amara A, Aboul-Enein A, Helmi S, Ballot A, Schnitzler P.

Pharmazie. 2013 May;68(5):376-80.

PMID:
23802437
17.

Chikungunya virus (CHIKV) inhibitors from natural sources: a medicinal chemistry perspective.

Bhakat S, Soliman ME.

J Nat Med. 2015 Oct;69(4):451-62. doi: 10.1007/s11418-015-0910-z. Epub 2015 Apr 29. Review.

18.

Spectral characterisation, antiviral activities, in silico ADMET and molecular docking of the compounds isolated from Tectona grandis to chikungunya virus.

K S, Purushothaman I, S R.

Biomed Pharmacother. 2017 Mar;87:302-310. doi: 10.1016/j.biopha.2016.12.069. Epub 2017 Jan 4.

PMID:
28063412
19.

Chikungunya virus: an update on antiviral development and challenges.

Kaur P, Chu JJ.

Drug Discov Today. 2013 Oct;18(19-20):969-83. doi: 10.1016/j.drudis.2013.05.002. Epub 2013 May 15. Review.

PMID:
23684571
20.

Continuing studies on the cyanobacterium Lyngbya sp.: isolation and structure determination of 15-norlyngbyapeptin A and lyngbyabellin D.

Williams PG, Luesch H, Yoshida WY, Moore RE, Paul VJ.

J Nat Prod. 2003 May;66(5):595-8.

PMID:
12762789

Supplemental Content

Support Center